From what I've been able to ferret out, it seems that partnerships are more likely. COV would actually be using the Radiopharmacological prodcut since they recently divested themselves of that product line.
Could be others that are looking to take advantage of the PET tech.
Sold this AM at .223 when it trended down, back in at .207. Looking for a bit of a run
News 
Market Data 
Discover 
